Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ganciclovir Dispersible Tablets

Approval Number

国药准字H20110082

Company湖北东信药业有限公司

Registration Date

April 7, 2021

Previous Approval Numbers

国药准字H20110082

Drug Information

Generic Name

更昔洛韦分散片

Brand Name

东信

Dosage Form

片剂

Strength

0.25g

Drug Type

化学药品

Registration Date

April 7, 2021

Company Information

Applicant Company

Company Name湖北东信药业有限公司

Company Address

湖北省荆州市沙市区观音垱镇汉沙街33号

Manufacturing Company

Company Name湖北东信药业有限公司

Company Address

湖北省荆州市沙市区观音垱镇汉沙街33号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

更昔洛韦分散片 - NMPA 批准文号 | MedPath